WAVE Life Sciences' IPO

WAVE Life Sciences raised a round of funding on November 11, 2015. Investors include Public.

WAVE Life Sciences is utilizing its synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause o…

Articles about WAVE Life Sciences' IPO: